author-photo

Joana M Oliveira

Eli Lilly and Company

4

Papers

28

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Immune profiling and clinical outcomes in patients treated with ramucirumab and pembrolizumab in phase I study JVDF.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (2)